Neoplastic salivary gland swellings

Pathological classification

  • 75% of tumours occur in parotid gland
    • 15% are malignant
  • 10% of tumours occur in submandibular gland
    • 30% are malignant
  • 15% of tumours occur in minor salivary glands
    • 50% are malignant

Benign

  • Pleomorphic adenoma (mixed parotid tumour)
  • Adenolymphoma (Warthin's tumours)
  • Haemangioma in children
  • Lymphangioma in children

Intermediate

  • Mucoepidermoid tumours
  • Acinic cell carcinoma
  • Oncocytoma

Malignant

  • Adenoid cystic carcinoma
  • Adenocarcinoma
  • Squamous cell carcinoma

Clinical features

  • Usually present as lump in the parotid region
  • Most are slow-growing even if malignant
  • Pain is suggestive of malignancy but is not a reliable symptom
  • Facial nerve palsy is highly suspicious of a malignant tumour
  • Extent of lesion can often be confirmed by CT or MRI scanning

MRI parotid tumour

Picture supplied by Vijay Ramachandran, Calicut Medical College, India

  • Open biopsy is contraindicated
  • Fine needle aspiration cytology may confirm diagnosis
  • Has a poor sensitivity but a high specificity

Pleomorphic adenoma

  • Accounts for 75% of parotid and 50% submandibular tumours
  • Initially described as a 'mixed' tumour
  • Believed to have both epithelial and mesothelial elements
  • Now appears to arise from ductal myoepithelial cells
  • Male : female ratio approximately equal
  • May undergo malignant change but risk is small
  • Requires excision with 5-10 mm margin as local implantation of cells can lead to recurrence

Large left pleomorphic adenoma

Picture provided by M H Randhawa, FMH College of Medicine and Dentistry

Recurrent pleomorphic adenoma after a superficial parotidectomy

Picture supplied by Dr T Bombardieri, Italy

Warthin's tumour

  • Also known as an adenolymphoma
  • Usually occurs in elderly patients
  • Male : female ratio is approximately 4:1
  • Accounts for 15% of parotid tumours
  • 10% of tumours are bilateral
  • Rare in other salivary glands
  • Do not undergo malignant change

Intermediate salivary tumours

  • Acinic cell and mucoepidermoid carcinomas account for 5% of all tumours
  • Have low malignant potential
  • Do not require radical therapy
  • Can be treated similar to benign tumours

Malignant salivary tumours

  • Adenoid cystic, adenocarcinomas and squamous cell tumours are rare
  • All are usually high grade tumours
  • Prognosis is often poor regardless of treatment
  • Adenoid cystic tumours have tendency for perineural spread into the brain
  • Also develop distant metastases to the lung
  • Cannon-ball metastases may be present for years without symptoms
  • Overall 5-year survival is approximately 50%

Management of salivary tumours

  • All tumours require partial or complete excision of the affected gland
  • Enucleation of benign tumours often results in local recurrence
  • In the parotid this involves either superficial or total parotidectomy
  • In both procedures the facial nerve is preserved
  • For malignant salivary tumours consideration should be given to:
    • Postoperative radiotherapy
    • Neck dissection if evidence of nodal involvement

Complications of salivary gland surgery

  • There are several specific complications
  • Can be divided into early and late
  • Early complications included
    • Haemorrhage and haematoma
    • Infection
    • Skin flap necrosis
    • Trismus
    • Salivary fistula
    • Nerve palsy
      • Facial nerve
      • Hypoglossal nerve
      • Lingual nerve
  • Late complications include
    • Frey's syndrome
    • Hyperaesthesia of local skin
    • Cosmetic defect
    • Tumour recurrence

Frey's syndrome

  • Relatively common complications after parotidectomy
  • May occur in up to 50% of patients undergoing superficial parotidectomy
  • Involves gustatory sweating of the face and auriculotemporal region
  • Due to regeneration of post-ganglionic secretomotor parasympathetic fibres
  • Follow path of post-ganglionic sympathetic fibres that supply sweat glands of the face
  • Symptoms can be reduced with botulinum toxin

Bibliography

Que Hee C G,  Perry C F.  Fine-needle aspiration cytology of parotid tumours:  is it useful?  Aust NZ J Surg 2001;  71:  345-348.

Sood S,  Quraishi M S,  Bradley P J.  Frey's syndrome and parotid surgery.  Clin Otolaryngol 1998;  23:  291-301.

Vaughan E D.  Management of malignant salivary gland tumours.  Hosp Med 2001;  62:  400-405.

Yu G Y.  Superficial parotidectomy through retrograde facial nerve dissection.  J R Coll Surg Ed 2001;  104-107.

 

 
 

Last updated: 03 January 2010

Copyright © 1997- 2010 Surgical-tutor.org.uk